我国中药基本药物存在的问题及建议

Problems in essential medicine of Chinese materia medica in China and some suggestions

分析我国中药基本药物存在的问题,提出相应建议,为完善我国具有中药特色的基本药物目录提供参考。采用文献研究的方法,通过借鉴国外经验和分析我国中药基本药物现状,阐述我国中药基本药物存在的5个主要问题:中药遴选多依靠专家经验,主观因素较多;中成药在国家基本药物目录中的比例不够明确;中药基本药物可获得性较差;中药注射剂质量安全隐患较多;中药不合理使用现象突出。提出完善我国中药基本药物的建议:加强循证决策,提高中药基本药物遴选依据的科学性;尽快明确中成药基本药物在国家基本药物目录中的比例;强化中药基本药物的配备和使用;加强对中药注射剂的不良反应监测和再评价工作;强化中药的引导和宣传,减少不合理用药。

To analyze the problems in the essential medicine of Chinese materia medica（CMM） in China and make the corresponding suggestions to provide a reference for the improvement of our characterized essential medicine list of CMM. By reviewing literatures, we learnt from foreign experience and analyzed the current situation of the essential medicine of CMM, stated the five primary problems existing in the part of the national essential medicine list of CMM, and proposed the suggestions. The problems are as follows： selection of the list in CMM is more based on the expertise with subjective factors; The proportion of the list in Chinese patent drug（CPD） is not clear; The access to the essential medicines of CMM is poor; There are many security risks with the quality of CMM injections and the prominent phenomenon of irrational use in CMM. The suggestions are as follows： to strengthen the evidence-based decision-making, improve the scientificity of the evidence in selecting the essential medicine of CMM, definite the proportion of the CPD in the list as soon as possible, strengthen the equipment and use of essential medicines of CMM, strengthen the ADR＇s monitoring and reevaluation of CMM injections, strengthen the guidance and advocacy of CMM, and reduce irrational drug use as well.